To explore this effect in vivo, we treated tumor-bearing homozygous TH-MYCN mice with 1 dose of brequinar and/or temozolomide and performed tumor immunohistochemistry on tumors labeling proliferating cells (Ki67) and apoptosis (active caspase-3). The gene discussed is CASP3; the disease is neoplasm.